Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma Anne-Gaëlle DosneElodie ValadeJuan Jose Perez Ruixo Original Article Open access 03 January 2022 Pages: 151 - 164
Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies Elmira KaramiShamsi NaderiFatemeh Kazemi-Lomedasht Original Article 06 January 2022 Pages: 165 - 172
Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis Mingrui YanXiaoyu FanYong Liu Original Article 06 January 2022 Pages: 173 - 181
Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway Peng XuHandong WangChulei Deng Original Article Open access 08 January 2022 Pages: 183 - 196
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach Manon RedaPauline MacaireAntonin Schmitt Original Article 08 January 2022 Pages: 197 - 208
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma Xi-zhi WenQiu-zhong PanXing Zhang Original Article 13 January 2022 Pages: 209 - 215
Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2 Lei ChenZhangke LiShiwen Guo Original Article 17 January 2022 Pages: 217 - 229
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in mice Brian F. KieselJianxia GuoJan H. Beumer Original Article 23 January 2022 Pages: 231 - 242
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota Junmin LiuWei LuoHongbo Sun Original Article Open access 23 January 2022 Pages: 243 - 253
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma Ryan H. MoyMegan GreallyGeoffrey Y. Ku Clinical Trial Report 23 January 2022 Pages: 255 - 265
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement Annalisa CondorelliCristina MatteoFrancesco Di Raimondo Short Communication 29 September 2021 Pages: 267 - 270
Lost in third space: altered tyrosine-kinase inhibitor pharmacokinetics in a patient with malignant ascites Stefanie D. KrensSasja F. MulderNielka P. van Erp Short Communication 01 December 2021 Pages: 271 - 274
Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment Kate R. SecombeElise E. CrameJoanne M. Bowen Short Communication 02 December 2021 Pages: 275 - 281
Correction to: Anticancer potential of metformin: focusing on gastrointestinal cancers Mohammad rafi KhezriHassan MalekinejadMorteza Ghasemnejad-Berenji Correction 02 August 2021 Pages: 283 - 283